Hims vs Shed: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats Shed overall, scoring 7.9/10 vs 7.8/10. Hims is more affordable at $175/mo vs $199/mo. Choose Hims for men who want glp-1 access from a well-known, publicly traded. Choose Shed for users who want fast delivery and a streamlined compounded gl.
A side-by-side comparison of Hims and Shed covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 40One of the largest and most recognized men's telehealth platforms in the US, offering compounded GLP-1 medications with a polished app experience and strong brand trust.
Visit HimsShed
#16 of 40Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.
Visit Shed| Feature | Hims | Shed |
|---|---|---|
| Our Score | 7.9/10 | 7.8/10 |
| Starting Price | $175/mo | $199/mo |
| Medication Type | Compounded | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 access from a well-known, publicly traded telehealth brand | Users who want fast delivery and a streamlined compounded GLP-1 experience |
| Ranking | #12 | #16 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +Polished app and web experience — one of the best user interfaces in men's telehealth
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Massive brand recognition and extensive customer support infrastructure
Cons
- −Pivoted away from some compounded formulations after FDA crackdown — medication availability can shift
- −Compounded only — no brand-name Wegovy or Zepbound through the platform
- −Generic support experience — large patient volume means less personalized attention
- −Higher price than competitors like TrimRx ($179) or Enhance MD ($115) for a similar compounded product
Shed
Pros
- +Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
- +$149/mo is competitively priced for an all-inclusive compounded program with good support
- +Streamlined onboarding with no video call — approved and shipped faster than most competitors
- +Clean, modern UX with real-time shipping tracking and easy provider messaging
Cons
- −Compounded semaglutide and tirzepatide only — no brand-name options
- −Newer company (founded 2024) with limited track record and outcome data
- −No insurance billing and no FSA/HSA superbills currently available
- −Clinical support is responsive but less proactive than premium platforms
Our Verdict
Hims edges out Shed with a score of 7.9/10 vs 7.8/10. If budget is your priority, Hims starts at $175/mo compared to Shed's $199/mo. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.